tallózása szerző szerint "Surowiak P"

1-14 / 14

ABCC2 (MRP2, cMOAT) localized in the nuclear envelope of breast carcinoma cells correlates with poor clinical outcome

Maciejczyk A; Jagoda E; Wysocka T; Matkowski R; Győrffy, Balázs; Lage H; Surowiak P (2012)
A comprehensive overview of targeted therapy in metastatic renal cell carcinoma

Mihály, Zsuzsanna; Sztupinszki, Zsófia; Surowiak P; Győrffy, Balázs (2012)

Chemotherapy and immunotherapy failed to deliver decisive results in the systemic treatment of metastatic renal cell carcinoma. Agents representing the current standards operate on members of the RAS signal transduction ...
Biomarkers for Systemic Therapy in Ovarian Cancer

Pénzváltó, Zsófia; Surowiak P; Győrffy, Balázs (2014)
Elevated BUBR1 Expression Is Associated with Poor Survival in Early Breast Cancer Patients : 15-Year Follow-up Analysis

Maciejczyk A; Szelachowska J; Czapiga B; Matkowski R; Hałoń A; Győrffy, Balázs; Surowiak P (2013)
Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients

Maciejczyk A; Lacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Halon A; Győrffy, Balázs; Lage H; Surowiak P (2013)
Enhanced immunoreactivity of TIMP-2 in the stromal compartment of tumor as a marker of favorable prognosis in ovarian cancer patients

Halon A; Nowak-Markwitz E; Donizy P; Matkowski R; Maciejczyk A; Gansukh T; Győrffy, Balázs; Spaczynski M; Zabel M; Lage H; Surowiak P (2012)

Degradation of the extracellular matrix and basement membrane is a critical step in tumor progression. Matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinase 2 (TIMP 2) act in a coordinated manner to ...
Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations

Győrffy, Balázs; Surowiak P; Kiesslich O; Denkert C; Schafer R; Dietel M; Lage H (2006)

Cancer patients with tumors of similar grading, staging and histogenesis can have markedly different treatment responses to different chemotherapy agents. So far, individual markers have failed to correctly predict resistance ...
Highly expressed genes are associated with inverse antisense transcription in mouse

Gyorffy A; Surowiak P; Tulassay, Zsolt; Győrffy, Balázs (2007)

There is a growing evidence, that antisense transcription might have a key role in a range of human diseases. Although predefined sense-antisense pairs were extensively studied, the antisense expression of the known sense ...
Identification of consensus genes and key regulatory elements in 5-fluoro-uracil resistance in gastric and colon cancer

Szőke D; Győrffy A; Surowiak P; Tulassay, Zsolt; Dietel M; Győrffy, Balázs (2007)

BACKGROUND: 5-fluorouracil (5-FU) is widely used in the treatment of gastric and colorectal cancer. Recent microrarray studies associated different gene lists with 5-FU resistance. A major challenge in the genomic era is ...
Loss of estrogen receptor beta expression correlates with shorter overall survival and lack of clinical response to chemotherapy in ovarian cancer patients

Halon A; Nowak-Markwitz E; Maciejczyk A; Pudelko M; Gansukh T; Győrffy, Balázs; Donizy P; Murawa D; Matkowski R; Spaczynski M; Lage H; Surowiak P (2011)

Background: Estrogen receptor beta (ERβ) belongs to a large family of nuclear receptors. Recent studies have suggested that ERβ in contrast to ERα might act as a tumour suppressor in ovarian cancer (OVCA). Materials and ...
Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers

Surowiak P; Materna V; Győrffy, Balázs; Matkowski R; Wojnar A; Maciejczyk A; Paluchowski P; Dziegiel P; Pudelko M; Kornafel J; Dietel M; Kristiansen G; Zabel M; Lage H (2006)

Determination of oestrogen receptor alpha (ER) represents at present the most important predictive factor in breast cancers. Data of ours and of other authors suggest that promising predictive/prognostic factors may also ...
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer

Győrffy Balázs; Surowiak P; Budczies J; Lánczky A (2013)
PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer

Munkácsy, Gyöngyi; Abdul-Ghani R; Mihály, Zsuzsanna; Tegze, Bálint; Tchernitsa; Surowiak P; Schafer R; Győrffy, Balázs (2010)

BACKGROUND: To date individual markers have failed to correctly predict resistance against anticancer agents in breast cancer. We used gene expression patterns attributable to chemotherapy-resistant cells to detect potential ...
Stromal myofibroblasts in breast cancer: relations between their occurrence, tumor grade and expression of some tumour markers

Surowiak P; Suchocki S; Győrffy, Balázs; Gansukh T; Wojnar A; Maciejczyk A; Pudelko M; Zabel M (2006)

It is suggested that tumour stromal myofibroblasts exert an unfavourable effect on the biology of breast cancer. We are aware of only a single study which examined relationships between manifestation of myofibroblasts ...

1-14 / 14

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban

Hozzáférésem

Bejelentkezés

tallózása szerző szerint "Surowiak P"

DSpace/Manakin Repository

tallózása szerző szerint "Surowiak P"

Keresés

Tallózás

Teljes repozitórumban

Hozzáférésem